Log in

TSE:MBXMicrobix Biosystems Stock Price, Forecast & News

C$0.34
0.00 (0.00 %)
(As of 06/5/2020 04:00 PM ET)
Add
Compare
Today's Range
C$0.32
Now: C$0.34
C$0.34
50-Day Range
C$0.28
MA: C$0.33
C$0.36
52-Week Range
C$0.17
Now: C$0.34
C$0.38
Volume138,200 shs
Average Volume212,581 shs
Market CapitalizationC$36.98 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Microbix Biosystems Inc., a life science company, manufactures viral and bacterial antigens and reagents for the diagnostics industry worldwide. The company produces infectious disease antigens, including viral, bacterial, and parasitic products, which are used in various applications, such as immunodiagnostic assays comprising ELISA, chemiluminescent automated immunoassays, immunohistochemistry, immunofluorescence, latex agglutination, rapid tests, and flow cytometry; controls for diagnostic assays. Its infectious disease antigens also used in controls for diagnostic assays, basic and applied research in virology, microbiology, cell biology, immunology, and pathology, or for vaccine and antiviral research and development. The company also provides quality assessment products, including PROCEEDx Verification/Validation samples, which are research use only products for use in test system IQ/OQ/PQ, verification/validation, and training; PTDx proficiency testing products; and REDx Controls, which are designed to enhance the diagnostic quality outcome by early detection of the deviations from desired assay performance. In addition, it develops Kinlytic Urokinase for injection, a thrombolytic biologic drug used to treat blood clots; and LumiSort cell-sorting, a technology for sorting of particles that could be used to enrich cell populations of interest, such as in sexing semen. Microbix Biosystems Inc. was founded in 1988 and is based in Mississauga, Canada.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.52 out of 5 stars


Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+1-905-3618910

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesC$11.62 million
Cash FlowC$0.00 per share
Book ValueC$0.11 per share

Profitability

Miscellaneous

EmployeesN/A
Market CapC$36.98 million
Next Earnings Date8/10/2020 (Estimated)
OptionableNot Optionable

Receive MBX News and Ratings via Email

Sign-up to receive the latest news and ratings for MBX and its competitors with MarketBeat's FREE daily newsletter.

Microbix Biosystems (TSE:MBX) Frequently Asked Questions

How has Microbix Biosystems' stock been impacted by COVID-19 (Coronavirus)?

Microbix Biosystems' stock was trading at C$0.22 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, MBX stock has increased by 54.5% and is now trading at C$0.34. View which stocks have been most impacted by Coronavirus.

When is Microbix Biosystems' next earnings date?

Microbix Biosystems is scheduled to release its next quarterly earnings announcement on Monday, August 10th 2020. View our earnings forecast for Microbix Biosystems.

Has Microbix Biosystems been receiving favorable news coverage?

News articles about MBX stock have trended somewhat negative on Saturday, according to InfoTrie. InfoTrie ranks the sentiment of media coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Microbix Biosystems earned a media sentiment score of -1.1 on InfoTrie's scale. They also gave media stories about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View the latest news aboutMicrobix Biosystems.

Who are some of Microbix Biosystems' key competitors?

What other stocks do shareholders of Microbix Biosystems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Microbix Biosystems investors own include TransAlta Renewables (RNW), Dynavax Technologies (DVAX), Heat Biologics (HTBX), Vaxart (VXRT), BlackBerry (BB), Canadian Western Bank (CWB), OrganiGram (OGI), Drone Delivery Canada (TAKOF), Acasti Pharma (ACST) and Aerie Pharmaceuticals (AERI).

Who are Microbix Biosystems' key executives?

Microbix Biosystems' management team includes the following people:
  • Mr. William J. Gastle, Founder & Exec. Chairman
  • Mr. Cameron Groome, Pres, CEO & Director
  • Mr. James S. Currie, Chief Financial Officer
  • Mr. Philip Casselli, Sr. VP of Sales, Bus. Devel. & Marketing
  • Mr. Vaughn C. Embro-Pantalony, Exec. Director

What is Microbix Biosystems' stock symbol?

Microbix Biosystems trades on the Toronto Stock Exchange (TSX) under the ticker symbol "MBX."

How do I buy shares of Microbix Biosystems?

Shares of MBX and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

What is Microbix Biosystems' stock price today?

One share of MBX stock can currently be purchased for approximately C$0.34.

How big of a company is Microbix Biosystems?

Microbix Biosystems has a market capitalization of C$36.98 million and generates C$11.62 million in revenue each year.

What is Microbix Biosystems' official website?

The official website for Microbix Biosystems is microbix.com.

How can I contact Microbix Biosystems?

Microbix Biosystems' mailing address is 265 Watline Ave, MISSISSAUGA, ON L4Z 1P3, Canada. The company can be reached via phone at +1-905-3618910.

This page was last updated on 6/6/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.